FDAFX Performance — Fidelity Advisor Freedom 2020 Fund, Class A
Data updated: 2026-08-24
FDAFX returned +6.74% year to date and +12.85% over one year to Jun 2026. Over one year the fund trailed its Target-Date category average: $100 grew to $113, against $118 for the category. Volatility over the past 12 months was 6.91% a year. In the 12 months to Jun 2026 the fund lost a net $104.5M, and assets reached $1.06B.
FDAFX Growth of $100
What $100 invested in Fidelity Advisor Freedom 2020 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | FDAFX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $113 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $42 | $150 |
| 5 years (Jul 2021 – Jun 2026) | $9 | $143 |
| Since data start (Jul 2019 – Jun 2026) | $3 | $187 |
FDAFX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.74% |
| 1 year | +12.85% |
3- and 5-year figures withheld: returns differ from sibling classes.
FDAFX Annual Returns
Calendar-year total returns of Fidelity Advisor Freedom 2020 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +6.74% |
| 2025 | +1.53% |
| 2024 | −47.52% |
| 2023 | −44.93% |
| 2022 | −58.88% |
| 2021 | −46.77% |
| 2020 | −44.48% |
| 2019 (Jul–Dec) | −25.77% |
FDAFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.9% | +2.1% | −4.0% | +4.6% | +1.7% | +0.5% | — | — | — | — | — | — |
| 2025 | −3.7% | −4.7% | −1.4% | +0.6% | +2.4% | +3.0% | +0.2% | +1.7% | +2.0% | +1.0% | +0.2% | +0.5% |
| 2024 | −5.8% | −4.4% | −3.7% | −8.5% | −3.0% | −4.8% | −3.8% | −4.0% | −4.1% | −8.1% | −4.0% | −8.2% |
| 2023 | −0.4% | −8.5% | −3.6% | −5.0% | −7.0% | −3.5% | −4.2% | −7.6% | −8.9% | −8.0% | +0.3% | −1.4% |
| 2022 | −8.7% | −7.6% | −6.5% | −11.2% | −5.5% | −11.1% | −1.3% | −8.7% | −12.8% | −3.5% | +0.3% | −8.2% |
| 2021 | −5.9% | −4.5% | −5.1% | −3.4% | −4.6% | −5.0% | −5.3% | −4.7% | −7.8% | −3.3% | −7.4% | −4.2% |
| 2020 | −6.2% | −8.8% | −14.3% | −0.1% | −2.8% | −3.3% | −2.5% | −3.1% | −7.2% | −6.6% | +0.9% | −2.6% |
| 2019 | — | — | — | — | — | — | −5.7% | −6.0% | −5.2% | −4.2% | −4.3% | −3.7% |
FDAFX Risk
Risk measures from monthly returns over Jul 2025 – Jun 2026.
- 1-year volatility (annualised): 6.91%
- Best month: +4.60% (Apr 2026)
- Worst month: −4.02% (Mar 2026)
FDAFX Fund Flows
Monthly money in and out of Fidelity Advisor Freedom 2020 Fund, from SEC Form N-PORT.
- 12-month net flow: −$104.5M
- 12-month gross sales (incl. reinvestments): $186.7M
- Sales ÷ redemptions: 0.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $9.9M | $22.9M | −$13.0M |
| May 2026 | $40.7M | $24.8M | $15.9M |
| Apr 2026 | $6.9M | $27.6M | −$20.7M |
| Mar 2026 | $11.8M | $28.2M | −$16.4M |
| Feb 2026 | $11.6M | $26.3M | −$14.6M |
| Jan 2026 | $10.4M | $23.7M | −$13.3M |
| Dec 2025 | $57.5M | $25.9M | $31.5M |
| Nov 2025 | $7.0M | $19.9M | −$12.8M |
| Oct 2025 | $7.1M | $23.9M | −$16.8M |
| Sep 2025 | $10.9M | $29.1M | −$18.2M |
| Aug 2025 | $6.6M | $18.9M | −$12.4M |
| Jul 2025 | $6.3M | $20.1M | −$13.8M |
FDAFX Assets Under Management
Net assets of Fidelity Advisor Freedom 2020 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.06B |
| 2026-03-31 | $1.04B |
| 2025-12-31 | $1.09B |
| 2025-09-30 | $1.11B |
| 2025-06-30 | $1.11B |
| 2025-03-31 | $1.10B |
| 2024-12-31 | $1.14B |
| 2024-09-30 | $1.25B |
| 2024-06-30 | $1.25B |
| 2024-03-31 | $1.30B |
| 2023-12-31 | $1.34B |
| 2023-09-30 | $1.29B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.